Avidity Biosciences Inc (RNA)
US Market

Avidity Biosciences (RNA) Stock Price & Analysis


RNA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$9.83 - $25.74
Previous Close$11.15
Average Volume (3M)1.34M
Market Cap
Enterprise Value$1.15B
Total Cash (Recent Filing)$118.71M
Total Debt (Recent Filing)$477.69M
Price to Earnings (P/E)-3.3
Aug 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.36
Shares Outstanding70,819,170
10 Day Avg. Volume867,657
30 Day Avg. Volume1,335,996
Standard Deviation0.21
Financial Highlights & Ratios
Price to Book (P/B)1.35
Price to Sales (P/S)353.62
Price to Cash Flow (P/CF)-3.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue118.88
Enterprise Value/Gross Profit124.53
Enterprise Value/Ebitda-5.95
Price Target Upside187.74% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Avidity Biosciences Inc’s price range in the past 12 months?
Avidity Biosciences Inc lowest stock price was $9.83 and its highest was $25.74 in the past 12 months.
    What is Avidity Biosciences Inc’s market cap?
    Currently, no data Available
    When is Avidity Biosciences Inc’s upcoming earnings report date?
    Avidity Biosciences Inc’s upcoming earnings report date is Aug 08, 2023 which is in 63 days.
      How were Avidity Biosciences Inc’s earnings last quarter?
      Avidity Biosciences Inc released its earnings results on May 09, 2023. The company reported -$0.74 earnings per share for the quarter, beating the consensus estimate of -$0.838 by $0.098.
        Is Avidity Biosciences Inc overvalued?
        According to Wall Street analysts Avidity Biosciences Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Avidity Biosciences Inc pay dividends?
          Avidity Biosciences Inc does not currently pay dividends.
          What is Avidity Biosciences Inc’s EPS estimate?
          Avidity Biosciences Inc’s EPS estimate is -$0.79.
            How many shares outstanding does Avidity Biosciences Inc have?
            Avidity Biosciences Inc has 70,819,170 shares outstanding.
              What happened to Avidity Biosciences Inc’s price movement after its last earnings report?
              Avidity Biosciences Inc reported an EPS of -$0.74 in its last earnings report, beating expectations of -$0.838. Following the earnings report the stock price went up 0.26%.
                Which hedge fund is a major shareholder of Avidity Biosciences Inc?
                Among the largest hedge funds holding Avidity Biosciences Inc’s share is RA Capital Management. It holds Avidity Biosciences Inc’s shares valued at 99M.


                  Avidity Biosciences Stock Smart Score

                  The Avidity Biosciences stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Avidity Biosciences Inc

                  Avidity Biosciences Inc is a bio-technology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease.


                  Top 5 ETFs holding RNA

                  Market Value
                  Smart Score
                  iShares Biotechnology ETF
                  Vanguard Health Care ETF
                  iShares Core S&P Total U.S. Stock Market ETF
                  Schwab U.S. Broad Market ETF
                  iShares NASDAQ US Biotechnology UCITS ETF
                  Up to five ETFs with an Outperform Smart Score that hold RNA. The ETFs are listed according to market value of RNA within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Arcturus Therapeutics
                  Arrowhead Pharmaceuticals
                  BioNTech SE
                  Crispr Therapeutics AG

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis